Skip to main content

Battle of the family SUVs: Hyundai Palisade vs Kia Telluride

The Kia Telluride and Hyundai Palisade have been among Edmunds’ favorite three-row SUVs for many years now. They boast roomy seating, classy designs, a generous number of features, and pricing that can potentially undercut the competition by thousands of dollars. But the “Telluride or Palisade?” decision can be tricky because the SUVs are mechanically related and share many similarities. It’s gotten even trickier now that both SUVs have received full redesigns.

Hyundai gave its 2026 Palisade a big makeover, complete with new styling, new technology features, and a newly available hybrid powertrain for mpg in the mid-30s. Kia has done much of the same for its just-released 2027 Telluride. But there are subtle differences between these two SUVs that you’ll want to know about. Edmunds’ auto experts have tested and compared the Telluride and Palisade to help you decide which one is the better SUV for your needs.

Interior space and conveniences

The Palisade and Telluride share the same general exterior dimensions but differ inside. The Palisade offers more front legroom, enough that you can order an optional front passenger seat with deep reclining angles and a footrest that mimics the functionality of your living room lounge chair. These lounge-style seats are also available as second-row captain’s chairs. The Telluride is certainly roomy and nice inside, but it doesn’t quite match the Palisade’s potential for royal poshness for its front and second-row passengers.

On paper, the Telluride offers more cargo space behind the third row. But in Edmunds’ testing, we found it couldn’t handle our hard-sided luggage without obstructing the liftgate. Here, the Palisade’s available power-sliding and reclining third row gave it an advantage, moving the seats forward enough to fit our suitcases.

Interior quality and ambience are evenly matched. The Telluride’s interior design has a linear and angular theme. The Palisade, meanwhile, looks to the past with soft curves and rounded edges that recall midcentury modern design. Both offer standard synthetic leather and available high-end leather upholstery. You’ll undoubtedly have your favorite, but we think the Palisade has a slight edge here for its superior daily utility and no-compromises luxury.

Winner: Palisade

Power and mpg

The Telluride comes standard with a 274-horsepower turbocharged four-cylinder engine, while the Palisade starts with a 287-horsepower V6. The V6’s added power looks good on the spec sheet, but we’ve found in our testing that the four-cylinder Telluride actually feels stronger and quicker for urgent highway merging and passing. At the Edmunds test track, the Palisade needed 8.8 seconds to accelerate from zero to 60 mph. The Telluride was quicker with its 8.1-second sprint.

Both models also offer an optional hybrid powertrain that combines a turbocharged four-cylinder and hybrid componentry to produce 329 horsepower and superior fuel economy. The front-wheel drive Telluride Hybrid is capable of an EPA-estimated 35 mpg combined, and the Palisade Hybrid is just a bit behind at 34 mpg. Notably, the hybrid versions are quick, too. Both hybrids accelerated from zero to 60 mph in around 7 seconds in Edmunds’ testing.

Winner: Telluride

Technology features

The Telluride and Palisade both nod to the future with a tour de force of displays, charging and connectivity. Both feature adjacent dual 12.3-inch displays, one for digital gauges and one for touchscreen infotainment and cabin controls. Apple CarPlay and Android Auto smartphone connectivity comes standard in both, but the Telluride offers the benefit of two standard wireless phone chargers, making it more convenient for you and the front passenger to charge at the same time.

Driver assistance and safety tech is nearly identical. Both models come with standard blind-spot alert, stop-and-go adaptive cruise control, and lane centering for relaxed highway cruising or crawling in heavy traffic. The driver still needs to keep hands on the wheel, but these SUVs can easily make highway driving less fatiguing.

Winner: tie

Price and value

The Hyundai Palisade starts at $41,035, including the destination fee. The hybrid costs an additional $4,725. The Telluride starts at $40,735 including destination, with a $7,300 premium to get into the hybrid. While the regular Telluride is slightly more affordable than its rival, the price gap between the entry-level hybrid trims is significant.

The Palisade Hybrid costs less and comes with standard second-row captain’s chairs, with optional bench seats for eight-passenger seating. The Telluride Hybrid is limited to seven passengers with its standard captain’s chairs. Both SUVs are backed by a five-year bumper-to-bumper warranty and an eight-year powertrain warranty.

Winner: Palisade

Edmunds says

Bold styling, great value and available hybrid mpg contribute to the Palisade and Telluride both being excellent picks for a family-friendly three-row SUV. But as you’re likely buying just one or the other, we think the Palisade’s richer luxury feel and more affordable hybrid give it a slight edge.

____________

This story was provided to The Associated Press by the automotive website Edmunds.

Dan Frio is a contributor at Edmunds.

When you have advanced prostate cancer: What living with the disease looks like

By WTOP Staff
(CNN) — “How long do I have to live ?”When I tell a patient he has prostate cancer, this is usually what he asks me first.With early-stage or low-grade prostate cancer, I can offer strong reassurance: Your life expectancy is good — expect a five-year relative survival rate of greater than 99% with treatment. Simply put, most men will not die from low-grade prostate cancer.However, once the cancer has spread outside the prostate to the bones and other organs the answer becomes more difficult. Treatment has changed dramatically over the past decade for advanced prostate cancer. New drugs, better imaging and the earlier use of combined therapies are helping men live longer.In a video released July 15, former President Joe Biden gave an update on his prostate cancer, saying he was receiving treatments that have been going well. In May 2025, Biden officially announced that he had an aggressive form of prostate cancer that had spread to his bones. Since then, based on official updates, he has continued hormone therapy, completed a course of radiation and maintained a public presence.His diagnosis brought renewed attention to prostate cancer screening and treatment. Now, more than a year later, his cancer journey offers an opportunity to examine what has changed in the treatment of advanced prostate cancer — and the hope these offer men living with the disease.I recently saw a patient who was diagnosed three years ago with cancer that had already spread to multiple areas in his bones. Since then, he has taken cruises, traveled with his family and spent weekends babysitting his grandchildren.He gets tired and cannot garden the way he once did. But he is still alive and considers every day a blessing. His experience, and what we see with Biden, shows what living with metastatic prostate cancer can look like today.Understanding survival ratesIf they haven’t asked their doctor already, many patients go online and find five-year survival rates, but every number they may find online comes with a huge asterisk.The American Cancer Society reports five-year relative survival of greater than 99% when prostate cancer is found in or near the prostate. The figure drops to 38% when it has reached distant parts of the body.But that number is based on large groups of men treated years ago. It does not fully reflect the impact of newer treatments — or account for an individual man’s age, overall health and response to therapy.Survival statistics describe groups of patients but do not predict what will happen to one person. That is why the 38% figure cannot tell us how long Biden — or any individual patient — will live. These patients’ outlook depends on details of their cancer and how they are responding to treatments.It’s treated more aggressively nowA man diagnosed with metastatic prostate cancer a decade ago and a man diagnosed today would not receive the same treatment. The thinking now is to use our best treatments early instead of holding back.For years, doctors began with hormone therapy — usually injections that lower testosterone — and saved other treatments until the cancer stopped responding.Today, those injections are often combined from the start with a newer hormone-blocking drug and/or chemotherapy. These combinations have helped men live longer and are one of the biggest shifts of the past decade.What Biden’s diagnosis told usThere are three details about Biden’s cancer that help doctors like me understand how aggressive it is and how to manage it effectively. Official statements highlighted that his cancer had a Gleason score of 9. The cancer had spread to his bones, and it was labeled as hormone-sensitive.The Gleason score is assigned after a pathologist examines biopsy samples. Scores typically range from 6 to 10, with higher numbers indicating more aggressive cancer. A score of 9 falls into the most aggressive category. However, the score alone cannot tell us whether the cancer has spread outside the prostate.When prostate cancer spreads, the most common destination is the bones — particularly the spine, pelvis and ribs. It can also reach organs such as the lungs or liver. Once it has reached distant parts of the body, it is generally not curable, but treatment can put a brake on it for years.Prostate cancer can also be hormone-sensitive or hormone-resistant. Because it typically relies on testosterone to grow, lowering the hormone or blocking its effects can help control the cancer. Hormone-sensitive means it still responds to these treatments.Over time, most advanced or metastatic prostate cancers find ways to grow despite low testosterone levels, which mean they are now hormone-resistant. Lowering testosterone alone is no longer enough to control the cancer, so doctors have to turn to additional therapies.Knowing if the cancer has spreadThe most sensitive imaging test available today is a PSMA PET scan. It uses a radioactive tracer that seeks out a protein found on the surface of prostate cancer cells. Areas containing cancer may appear as bright spots, helping identify where the cancer has spread. The American Urological Association supports using this imaging test to determine whether high-risk prostate cancer has spread and to help establish its stage.A traditional bone scan, used for decades, highlights areas where bone is reacting to injury or disease. It remains an alternative imaging option, but PSMA PET is increasingly replacing its use.What areas light up and where matter when deciding on treatments. A single spot in the spine and cancer that has spread to the liver are both called stage 4, but they are not the same disease and may not be treated the same way.Doctors also consider how much cancer has spread. We label it as “low-volume” disease when the cancer has reached a limited number of areas. High volume is when the spread is more widespread or has reached other organs such as the liver or lungs.Both require treatment that works throughout the body. Treatment for metastatic disease generally includes therapy that works throughout the body. For men with low-volume disease, adding radiation to the prostate may also help them live longer.Biden has completed a course of radiation, but his team has not disclosed what area was treated or enough detail to determine whether his cancer would be considered low- or high-volume.Treatment has become more preciseBeyond starting more treatments earlier, doctors can increasingly tailor therapy to the biology of an individual man’s cancer. We can now test both the tumor and a patient’s own DNA for mutations that help guide treatment.Roughly 1 in 10 men with metastatic prostate cancer carries an inherited mutation affecting the body’s ability to repair DNA. The best known are BRCA1 and BRCA2, the same genes linked to some breast and ovarian cancers.Certain mutations found in the tumor or inherited DNA may make targeted drugs called PARP inhibitors an option. If a mutation is inherited, it also gives family members information they can act on through genetic counseling, testing and earlier screening.Another advance is radioligand therapy. If a scan shows that cancer cells carry a protein called PSMA, doctors can attach radiation to a molecule that seeks out that protein. Delivered through an IV, it targets cancer cells throughout the body. This approach was expanded last year to more men whose cancer had become hormone resistant.Living longer can come with costsEvery treatment can cause side effects. With hormone therapy, one of the first is often hot flashes, similar to what women experience during menopause. These are not dangerous, but they can affect a man’s quality of life.Fatigue is also common. Testosterone helps maintain muscle, so lowering it can reduce strength and energy. Regular walking and resistance training can help preserve muscle and reduce fatigue.The side effect almost no one talks about is loss of sex drive or low libido. At diagnosis, most men are thinking about staying alive, not their libido. But months later, it often matters. It is worth discussing with your care team and your partner rather than assuming it is simply the price of treatment.The side effect I worry about most is weaker bones. Low testosterone reduces bone density, while cancer deposits can weaken the bone’s structure. Follow-up care should include exercise, a bone-density scan, and ensuring adequate levels of calcium and vitamin D. For men with hormone-resistant cancer that has spread to bone, bone-protecting drugs can reduce the risk of fractures and other complications.New or worsening back pain, especially with leg weakness, numbness or trouble controlling the bladder or bowels? These could mean the cancer is pressing on the spinal cord. It is a true medical emergency that requires immediate attention.Cancer care requires a team approachIdeally, several doctors work together to coordinate a patient’s care. The urologist is often the starting point. A medical oncologist manages treatments that work throughout the body, while a radiation oncologist targets specific areas, whether that is the prostate itself or a painful bone lesion. The primary care doctor helps protect the patient’s heart and bones and looks after the person’s overall health.A man’s age, other medical conditions, ability to tolerate side effects and goals for treatment all shape treatment plans. Two men with nearly identical test results may be offered — or choose — different paths based on their health and priorities.Good communication among doctors is essential, but gaps can happen. Being your own advocate means knowing who is on your care team, asking questions and understanding your options.I also recommend bringing someone you trust to important visits for support and to take notes and help you remember what was discussed.More treatments, better testing offer hopeFor men worried about prostate cancer, talk with your health care provider about the benefits and risks of PSA testing. Black men and those with a strong family history should begin that conversation in their 40s. New urinary symptoms are often not cancer, but they still deserve attention, as does blood in the urine or semen, unexplained weight loss and/or persistent back or bone pain.For men living with advanced prostate cancer, there is reason for hope. There are more treatments and better testing than there were a decade ago, and good care pays attention to how a man feels, not just to what his scans show.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story

Related Stories

Superman
Lifestyle News
This is the headline
June 29, 2026
Superman

This is the headline

Photo Sep 24 2025 5 14 29 PM 1672x1254

test

Obama Presidential Center

Inside Obama's presidential museum opening this month: The cost, the books and a beehive

Obama Presidential Center

Presidential museum showcases political and personal sides of Obama with sprawling community campus

Be Well Admin Dates

A new kind of date makes personal to-do lists a reason to get together with friends